Characterization of gastric adenocarcinoma cell lines established from CEA424/SV40 T antigen-transgenic mice with or without a human CEA transgene
2006

New Mouse Models for Gastric Cancer Research

Sample size: 8 publication Evidence: moderate

Author Information

Author(s): Jessica Nöckel, Natasja K van den Engel, Hauke Winter, Rudolf A Hatz, Wolfgang Zimmermann, Robert Kammerer

Primary Institution: Ludwig-Maximilians-University, Munich, Germany

Hypothesis

The study aims to establish murine in vivo models to improve immunotherapies for gastric cancer.

Conclusion

The established tumor cell lines can be used to optimize immunotherapy regimens for gastric cancer.

Supporting Evidence

  • The cell lines were established from gastric tumors of transgenic mice.
  • All cell lines were tumorigenic when grafted into syngeneic hosts.
  • Immunization with tumor cell lysates protected mice from tumor challenge.

Takeaway

Scientists created new mouse models to help test treatments for stomach cancer, which can be really hard to treat.

Methodology

Four cell lines were established from CEA424/SV40 T antigen-transgenic mice and three from double-transgenic mice, followed by various assays to assess tumorigenicity and immunogenicity.

Limitations

The study does not address the long-term efficacy of the immunotherapy strategies tested.

Participant Demographics

Mice used were C57BL/6 and various transgenic strains.

Digital Object Identifier (DOI)

10.1186/1471-2407-6-57

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication